Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($2.00) EPS for the quarter, missing the consensus estimate of $0.19 by ($2.19), Zacks reports. The business had revenue of $314.39 million for the quarter, compared to analyst estimates of $303.21 million. Guardian Pharmacy Services updated its FY 2024 guidance to EPS.
Guardian Pharmacy Services Trading Up 1.2 %
Shares of NYSE GRDN traded up $0.26 during midday trading on Friday, reaching $21.26. 21,129 shares of the stock were exchanged, compared to its average volume of 155,695. Guardian Pharmacy Services has a 52-week low of $14.16 and a 52-week high of $23.05.
Insider Buying and Selling at Guardian Pharmacy Services
In other news, Director Thomas J. Salentine, Jr. bought 35,714 shares of Guardian Pharmacy Services stock in a transaction that occurred on Friday, September 27th. The shares were purchased at an average price of $14.00 per share, for a total transaction of $499,996.00. Following the completion of the acquisition, the director now owns 35,714 shares of the company’s stock, valued at $499,996. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Wall Street Analysts Forecast Growth
Get Our Latest Report on Guardian Pharmacy Services
Guardian Pharmacy Services Company Profile
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Further Reading
- Five stocks we like better than Guardian Pharmacy Services
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Top-Performing Non-Leveraged ETFs This Year
- How to Effectively Use the MarketBeat Ratings Screener
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- Stock Dividend Cuts Happen Are You Ready?
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.